IHC was performed by fixing the eyes in 4% paraformaldehyde and serial sucrose saturation with 10%, 20%, and then 30% sucrose concentrations. The tissue was embedded in Tissue-Tek O.C.T. Compound (4583; Sakura Finetek, Torrance, CA) and was sectioned at a thickness of 12 mm. Corneas were blocked and permeabilized with PBS containing 0.1% Triton X-100 and 5% bovine serum albumin (BSA) for 90 minutes at room temperature. The cells were then incubated overnight at 4°C with primary antibodies diluted in PBS containing 1% BSA and 0.1% Triton X-100. Primary antibodies were rabbit anti-K13 (lot #3202400), diluted 1:100; rabbit anti-K12 (ab185627; Abcam, Cambridge, UK), diluted 1:100; mouse anti–α-smooth muscle actin (α-SMA) monoclonal antibody (A2547; Sigma-Aldrich, St. Louis, MO), diluted 1:400; and rabbit anti–βIII-tubulin antibody (ab18207; Abcam), diluted 1:500. The appropriate secondary antibodies were applied at a 1:500 dilution. Finally, the eyes were flatmounted with Invitrogen ProLong Gold Antifade Mountant with DNA Stain DAPI (P36935; Thermo Fisher Scientific) and examined with confocal microscopy (FV1000; Olympus, Tokyo, Japan). The corneal epithelial height and βIII-tubulin expression at the center of the corneal epithelium were measured using ImageJ (National Institutes of Health, Bethesda, MD) with slides of two eyes from each group. The corneal fibrosis amount was evaluated by measuring subepithelial α-SMA expression thickness by ImageJ.